SCHEMBL2116125

SCHEMBL2116125

N#Cc1ccc(-c2nc(Cl)c(Cl)c(Cl)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.43
ABCG2 Q9UNQ0 4/20 0.42
ABCB1 P08183 2/20 0.42
MMP3 P08254 1/20 0.42
RHEB Q15382 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
HRH4 Q9H3N8 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
CASP1 P29466 1/20 0.40
GAA P10253 1/20 0.40
CYP11B2 P19099 1/20 0.39
CYP19A1 P11511 1/20 0.39
NOTUM Q6P988 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
KIF11 P52732 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2479265 0.83 MMP3 (0.52) ABCG2ABCB1MMP3HRH4ALDH1A1
SCHEMBL20222785 0.82 ABCG2 (0.44) ABCG2ABCB1MMP3RHEBHRH4
SCHEMBL20718783 0.82 ABCG2 (0.44) ABCG2ABCB1MMP3RHEBHRH4
SCHEMBL375967 0.76 NPC1 (0.58) LMNAMEN1KMT2AALDH1A1NOTUM
SCHEMBL29450769 0.76 ABCG2 (0.54) ABCG2ABCB1MEN1KMT2AALDH1A1
SCHEMBL22073476 0.76 ABCG2 (0.54) LMNAABCG2ABCB1HPGDGAA
SCHEMBL21849416 0.76 ABCG2 (0.54) ABCG2ABCB1MEN1KMT2AALDH1A1
SCHEMBL31612415 0.76 ABCG2 (0.54) LMNAABCG2ABCB1HPGDGAA
SCHEMBL5733814 0.76 MAPK1 (0.43) MEN1KMT2AALDH1A1HPGDGAA
SCHEMBL6075299 0.76 NSD2 (0.46) MEN1KMT2AALDH1A1HPGDCYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101646657-B Process for producing trichloropyrimidine compound SUMITOMO CHEMICAL CO JP 2012-08-08 CN disclosed
US-8158787-B2 Process for producing trichloropyrimidine compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-04-17 US disclosed
US-20100160630-A1 PROCESS FOR PRODUCING TRICHLOROPYRIMIDINE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-24 US disclosed
EP-2128141-A1 PROCESS FOR PRODUCING TRICHLOROPYRIMIDINE COMPOUND Sumitomo Chemical Company, Limited (JP) 2009-12-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160630-A1 PROCESS FOR PRODUCING TRICHLOROPYRIMIDINE COMPOUND DPYD, TYMP, TST LMNA 4884/4885ABCG2 869/4885ABCB1 2879/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.